Claims for Patent: 6,960,577

Summary for Patent: 6,960,577

Title:	Combination therapy for treatment of refractory depression
Abstract:	Methods for treating a patient suffering from or susceptible to treatment resistant major depression comprising administering olanzapine and fluoxetine are disclosed.
Inventor(s):	Tollefson; Gary Dennis (Indianapolis, IN)
Assignee:	Eli Lilly and Company (Indianapolis, IN)
Application Number:	10/144,159
Patent Claims:	1. A method for treating a patient suffering from or susceptible to treatment resistant major depression, comprising administering to said patient an effective amount of a first component which is olanzapine or a pharmaceutically acceptable salt thereof, in combination with an effective amount of a second component which is fluoxetine, or a phannaceutically acceptable salt thereof. 2. A method according to claim 1 where the administration of the compounds is oral. 3. A method for treating a patient suffering from or susceptible to treatment resistant major depression, comprising administering to said patient an effective amount of a first component which is olanzapine, in combination with an effective amount of a second component which is fluoxetine. 4. A method for treating a patient suffering from or susceptible to treatment resistant major depression, comprising administering to said patient an effective amount of a first component which is olanzapine in combination with an effective amount of a second component which is fluoxetine hydrochloride.